80_FR_69448 80 FR 69232 - National Institute on Drug Abuse; Notice of Closed Meeting

80 FR 69232 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 216 (November 9, 2015)

Page Range69232-69232
FR Document2015-28386

Federal Register, Volume 80 Issue 216 (Monday, November 9, 2015) 
[Federal Register Volume 80, Number 216 (Monday, November 9, 2015)]
[Notices]
[Page 69232]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-28386]



[[Page 69232]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Multi-site Clinical Trials.
    Date: November 23, 2015.
    Time: 2:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Virtual Meeting).
    Contact Person: Susan O. McGuire, Ph.D., Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd., 
Room 4245, Rockville, MD 20852, 301-435-1426, 
[email protected].

Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: November 2, 2015.
Natasha Copeland,
 Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-28386 Filed 11-6-15; 8:45 am]
BILLING CODE 4140-01-P

69232 Federal Register / Vol. 80, No. 216 / Monday, November 9, 2015 / Notices DEPARTMENT OF HEALTH AND provisions set forth in section 552b(c)(4) applications, the disclosure of which HUMAN SERVICES and 552b(c)(6), Title 5 U.S.C., as would constitute a clearly unwarranted amended. The grant applications and invasion of personal privacy. National Institutes of Health the discussions could disclose Name of Committee: Center for Scientific confidential trade secrets or commercial Review Special Emphasis Panel; Member National Institute on Drug Abuse; property such as patentable material, Conflict: Infectious, Reproductive, Asthma Notice of Closed Meeting and personal information concerning and Pulmonary Epidemiology. Pursuant to section 10(d) of the individuals associated with the grant Date: November 13, 2015. Federal Advisory Committee Act, as applications, the disclosure of which Time: 1:30 p.m. to 3:00 p.m. amended (5 U.S.C. App), notice is would constitute a clearly unwarranted Agenda: To review and evaluate grant hereby given of the following meeting. invasion of personal privacy. applications. The meeting will be closed to the Place: National Institutes of Health, 6701 Name of Committee: National Institute of Child Health and Human Development Rockledge Drive, Bethesda, MD 20892 public in accordance with the Special Emphasis Panel, (Telephone Conference Call). provisions set forth in sections Neurodevelopmental Assessment of Infants Contact Person: Denise Wiesch, Ph.D., 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Scientific Review Officer, Center for and Children in Resource-Limited Settings. as amended. The grant applications and Date: November 19, 2015. Scientific Review, National Institutes of the discussions could disclose Time: 1:00 p.m. to 4:00 p.m. Health, 6701 Rockledge Drive, Room 3138, confidential trade secrets or commercial Agenda: To review and evaluate grant MSC 7770, Bethesda, MD 20892, (301) 437– property such as patentable materials, applications. 3478, wieschd@csr.nih.gov. and personal information concerning Place: National Institutes of Health, 6100 This notice is being published less than 15 individuals associated with the grant Executive Boulevard, Rockville, MD 20852 days prior to the meeting due to the timing applications, the disclosure of which (Telephone Conference Call). limitations imposed by the review and would constitute a clearly unwarranted Contact Person: Sathasiva B. Kandasamy, funding cycle. Ph.D., Scientific Review Officer, Scientific invasion of personal privacy. Review Branch, Eunice Kennedy Shriver Name of Committee: Center for Scientific Name of Committee: National Institute on National Institute of Child Health and Review Special Emphasis Panel; Program Drug Abuse Special Emphasis Panel; Multi- Human Development, NIH, 6100 Executive Project: Multi-Use Knowledge Base and site Clinical Trials. Boulevard, Room 5B01, Bethesda, MD Computational Modeling of Human Date: November 23, 2015. 20892–9304, (301) 435–6680, skandasa@ Metabolism. Time: 2:00 p.m. to 4:00 p.m. mail.nih.gov. Date: December 3, 2015. Agenda: To review and evaluate grant This notice is being published less than 15 Time: 1:00 p.m. to 4:00 p.m. applications. days prior to the meeting due to the timing Agenda: To review and evaluate grant Place: National Institutes of Health, limitations imposed by the review and applications. Neuroscience Center, 6001 Executive funding cycle. Place: National Institutes of Health, 6701 Boulevard, Rockville, MD 20852, (Virtual (Catalogue of Federal Domestic Assistance Rockledge Drive, Bethesda, MD 20892 Meeting). Program Nos. 93.864, Population Research; (Virtual Meeting). Contact Person: Susan O. McGuire, Ph.D., 93.865, Research for Mothers and Children; Contact Person: Amy L Rubinstein, Ph.D., Scientific Review Officer, Office of 93.929, Center for Medical Rehabilitation Scientific Review Officer, Center for Extramural Affairs, National Institute on Research; 93.209, Contraception and Scientific Review, National Institutes of Drug Abuse, National Institutes of Health, Infertility Loan Repayment Program, National Health, 6701 Rockledge Drive, Room 5152, DHHS, 6001 Executive Blvd., Room 4245, Institutes of Health, HHS) MSC 7844, Bethesda, MD 20892, 301–408– Rockville, MD 20852, 301–435–1426, Dated: November 3, 2015. 9754, rubinsteinal@csr.nih.gov. mcguireso@mail.nih.gov. Michelle Trout, Name of Committee: Center for Scientific Catalogue of Federal Domestic Assistance Program Analyst, Office of Federal Advisory Review Special Emphasis Panel; Program Program Nos.: 93.279, Drug Abuse and Committee Policy. Project: National Resource for Challenges in Addiction Research Programs, National [FR Doc. 2015–28383 Filed 11–6–15; 8:45 am] RNA Research. Institutes of Health, HHS) BILLING CODE 4140–01–P Date: December 6–8, 2015. Dated: November 2, 2015. Time: 7:00 p.m. to 12:00 p.m. Natasha Copeland, Agenda: To review and evaluate grant Program Analyst, Office of Federal Advisory DEPARTMENT OF HEALTH AND applications, Committee Policy. Place: Courtyard Albany Thruway, 1455 HUMAN SERVICES Washington Ave., Albany, NY 12206. [FR Doc. 2015–28386 Filed 11–6–15; 8:45 am] National Institutes of Health Contact Person: Barbara J. Thomas, Ph.D., BILLING CODE 4140–01–P Scientific Review Officer, Center for Center for Scientific Review; Notice of Scientific Review, National Institutes of Closed Meetings Health, 6701 Rockledge Drive, Room 2218, DEPARTMENT OF HEALTH AND MSC 7890, Bethesda, MD 20892, 301–435– HUMAN SERVICES Pursuant to section 10(d) of the 0603, bthomas@csr.nih.gov. Federal Advisory Committee Act, as (Catalogue of Federal Domestic Assistance National Institutes of Health amended (5 U.S.C. App.), notice is Program Nos. 93.306, Comparative Medicine; Eunice Kennedy Shriver National hereby given of the following meetings. 93.333, Clinical Research, 93.306, 93.333, The meetings will be closed to the 93.337, 93.393–93.396, 93.837–93.844, Institute of Child Health And Human public in accordance with the 93.846–93.878, 93.892, 93.893, National Development; Notice of Closed Institutes of Health, HHS) provisions set forth in sections srobinson on DSK5SPTVN1PROD with NOTICES Meeting 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and Dated: November 3, 2015. Pursuant to section 10(d) of the Federal Advisory Committee Act, as the discussions could disclose Natasha Copeland, amended (5 U.S.C. App.), notice is confidential trade secrets or commercial Program Analyst, Office of Federal Advisory hereby given of the following meeting. property such as patentable material, Committee Policy. The meeting will be closed to the and personal information concerning [FR Doc. 2015–28384 Filed 11–6–15; 8:45 am] public in accordance with the individuals associated with the grant BILLING CODE 4140–01–P VerDate Sep<11>2014 19:52 Nov 06, 2015 Jkt 238001 PO 00000 Frm 00045 Fmt 4703 Sfmt 9990 E:\FR\FM\09NON1.SGM 09NON1


Document Created: 2015-12-14 15:05:40
Document Modified: 2015-12-14 15:05:40
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesNovember 23, 2015.
FR Citation80 FR 69232 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR